Wogonin has been shown to exert significant anti-cancer activity, alone or in combination with other therapies in leukemia, possibly through CDK9-mediated p53 phosphorylation (Ball and Abdel-Wahab, 2018). This evidence concerns the gene TP53 and cancer.